Treatment of Cancer: Biontech and U.S. Group Co-Operation with Billions of Dollars
5 Articles
5 Articles
Millions of Biontech shareholders have been hoping for years for a continuation of the stock market story. But the long-awaited breakthrough in cancer drugs has been waiting for you. Now, however, the Mainz Group surprises with a message reminiscent of the Covid-19 coup.
For many, Biontech is more known as a developer of the Covid vaccine. Mainzers have always been dedicated to the fight against cancer. Cooperation with a US company is now supposed to help.


Here you will find information on the topic "Treatment of Cancer". Read now "Billion-severe cooperation between Biontech and the US company" .
A new drug from the Mainz-based company BioNTech is to be used against several types of cancer. It arouses great hopes. A US partner supports with billions.
Coverage Details
Bias Distribution
- 67% of the sources lean Left
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage